{
    "2020-02-12": [
        [
            {
                "time": "",
                "original_text": "国内首个抗ED药物获批用于治疗罕见病“蓝嘴唇”",
                "features": {
                    "keywords": [
                        "抗ED药物",
                        "获批",
                        "罕见病",
                        "蓝嘴唇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-02-12",
                "original_text": "智通港股通占比异动统计|2月12日",
                "features": {
                    "keywords": [
                        "港股通",
                        "占比异动",
                        "统计"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "港股市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}